Figure 6
Figure 6. Reactivity of KK10-specific CD8+ T-cell populations to emerging L268M mutants. (A) Ag sensitivity of KK10-specific CD8+ T-cell populations from 4 HLA-B*2705+ individuals infected with HIV-1 was measured directly ex vivo using IFN-γ ELISPOT analysis across a range of wt KK10 and mutant L268M peptide concentrations. The patients harbored predominantly either wt (02.011) or L268M (11.007, 01.225, and 05.005) viruses at the time point studied. (B) SFC ratio of wt/L268M-specific responses are plotted for each patient. Ratios were calculated for each peptide concentration and are shown as the mean ± SEM for all peptide concentrations. (C) Ag sensitivity (EC50 values) for the wt KK10 and mutant L268M peptides in each individual. SFC indicates spot-forming cell.

Reactivity of KK10-specific CD8+ T-cell populations to emerging L268M mutants. (A) Ag sensitivity of KK10-specific CD8+ T-cell populations from 4 HLA-B*2705+ individuals infected with HIV-1 was measured directly ex vivo using IFN-γ ELISPOT analysis across a range of wt KK10 and mutant L268M peptide concentrations. The patients harbored predominantly either wt (02.011) or L268M (11.007, 01.225, and 05.005) viruses at the time point studied. (B) SFC ratio of wt/L268M-specific responses are plotted for each patient. Ratios were calculated for each peptide concentration and are shown as the mean ± SEM for all peptide concentrations. (C) Ag sensitivity (EC50 values) for the wt KK10 and mutant L268M peptides in each individual. SFC indicates spot-forming cell.

Close Modal

or Create an Account

Close Modal
Close Modal